Computational design of new Peptide inhibitors for amyloid Beta (aβ) aggregation in Alzheimer's disease: application of a novel methodology.
Alzheimer's disease is the most common form of dementia. It is a neurodegenerative and incurable disease that is associated with the tight packing of amyloid fibrils. This packing is facilitated by the compatibility of the ridges and grooves on the amyloid surface. The GxMxG motif is the major...
Saved in:
Main Authors: | Gözde Eskici, Mert Gur |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/66201b7b33f74fcf9dc37cb4952362a3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effective screen for amyloid β aggregation inhibitor using amyloid β-conjugated gold nanoparticles
by: Sun-Ho Han, et al.
Published: (2010) -
Shedding Light on Alzheimer’s β-Amyloidosis: Photosensitized Methylene Blue Inhibits Self-Assembly of β-Amyloid Peptides and Disintegrates Their Aggregates
by: Byung Il Lee, et al.
Published: (2017) -
The nickel-chelator dimethylglyoxime inhibits human amyloid beta peptide in vitro aggregation
by: Stéphane L. Benoit, et al.
Published: (2021) -
Publisher Correction: Crocus-derived compounds alter the aggregation pathway of Alzheimer’s Disease - associated beta amyloid protein
by: Nikolaos Stavros Koulakiotis, et al.
Published: (2021) -
A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer’s Disease
by: Ebrima Gibbs, et al.
Published: (2019)